318 related articles for article (PubMed ID: 23291628)
1. Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus.
Ouyang H; Shi Y; Liu Z; Feng S; Li L; Su N; Lu Y; Kong S
Mol Med Rep; 2013 Mar; 7(3):1031-7. PubMed ID: 23291628
[TBL] [Abstract][Full Text] [Related]
2. [Abnormality and significance of interleukin-9 and CD4(+)interleukin-9(+) T-cells in peripheral blood of patients with systemic lupus erythematosus].
Ouyang H; Shi YB; Su N; Li LY
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):99-103. PubMed ID: 23648344
[TBL] [Abstract][Full Text] [Related]
3. Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus.
Ouyang H; Shi YB; Liu ZC; Wang Z; Feng S; Kong SM; Lu Y
Am J Med Sci; 2014 Aug; 348(2):156-61. PubMed ID: 25054737
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.
Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q
Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138
[TBL] [Abstract][Full Text] [Related]
5. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
6. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
9. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus.
Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y; Feng L
Exp Biol Med (Maywood); 2013 Feb; 238(2):193-9. PubMed ID: 23576801
[TBL] [Abstract][Full Text] [Related]
10. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
11. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
12. E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.
Zhao M; Liu Q; Liang G; Wang L; Luo S; Tang Q; Zhao H; Su Y; Yung S; Chan TM; Lu Q
J Autoimmun; 2013 Mar; 41():152-60. PubMed ID: 23340290
[TBL] [Abstract][Full Text] [Related]
13. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
[TBL] [Abstract][Full Text] [Related]
14. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides.
Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P
J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240
[TBL] [Abstract][Full Text] [Related]
15. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
16. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
17. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
18. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
20. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.
Yang PT; Kasai H; Zhao LJ; Xiao WG; Tanabe F; Ito M
Clin Exp Immunol; 2004 Nov; 138(2):342-7. PubMed ID: 15498047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
